Roth JC - Search Results

1

Evaluation of adenovirus capsid labeling versus transgene expression.

Li J, Fatima A, Komarova S, Ugai H, Uprety P, Roth JC, Wang M, Oster RA, Curiel DT, Matthews QL. Li J, et al. Among authors: roth jc. Virol J. 2010 Jan 26;7:21. doi: 10.1186/1743-422X-7-21. Virol J. 2010. PMID: 20102632 Free PMC article.

2

Targeting EGFR with metabolically biotinylated fiber-mosaic adenovirus.

Pereboeva L, Komarova S, Roth J, Ponnazhagan S, Curiel DT. Pereboeva L, et al. Gene Ther. 2007 Apr;14(8):627-37. doi: 10.1038/sj.gt.3302916. Epub 2007 Jan 25. Gene Ther. 2007. PMID: 17251987 Free PMC article.

3

Derivation of a myeloid cell-binding adenovirus for gene therapy of inflammation.

Alberti MO, Roth JC, Ismail M, Tsuruta Y, Abraham E, Pereboeva L, Gerson SL, Curiel DT. Alberti MO, et al. Among authors: roth jc. PLoS One. 2012;7(5):e37812. doi: 10.1371/journal.pone.0037812. Epub 2012 May 18. PLoS One. 2012. PMID: 22624065 Free PMC article.

4

Targeting of mesenchymal stem cells to ovarian tumors via an artificial receptor.

Komarova S, Roth J, Alvarez R, Curiel DT, Pereboeva L. Komarova S, et al. J Ovarian Res. 2010 May 25;3:12. doi: 10.1186/1757-2215-3-12. J Ovarian Res. 2010. PMID: 20500878 Free PMC article.

5

Cell vehicle targeting strategies.

Roth JC, Curiel DT, Pereboeva L. Roth JC, et al. Gene Ther. 2008 May;15(10):716-29. doi: 10.1038/gt.2008.38. Epub 2008 Mar 27. Gene Ther. 2008. PMID: 18369326 Review.

6

A myeloid cell-binding adenovirus efficiently targets gene transfer to the lung and escapes liver tropism.

Alberti MO, Deshane JS, Chaplin DD, Pereboeva L, Curiel DT, Roth JC. Alberti MO, et al. Among authors: roth jc. Gene Ther. 2013 Jul;20(7):733-41. doi: 10.1038/gt.2012.91. Epub 2012 Nov 22. Gene Ther. 2013. PMID: 23171918 Free PMC article.

7

Characterization of infectivity of knob-modified adenoviral vectors in glioma.

Paul CP, Everts M, Glasgow JN, Dent P, Fisher PB, Ulasov IV, Lesniak MS, Stoff-Khalili MA, Roth JC, Preuss MA, Dirven CM, Lamfers ML, Siegal GP, Zhu ZB, Curiel DT. Paul CP, et al. Among authors: roth jc. Cancer Biol Ther. 2008 May;7(5):786-93. doi: 10.4161/cbt.7.5.5421. Cancer Biol Ther. 2008. PMID: 18756624 Free article.

8

Long-term-infected telomerase-immortalized endothelial cells: a model for Kaposi's sarcoma-associated herpesvirus latency in vitro and in vivo.

An FQ, Folarin HM, Compitello N, Roth J, Gerson SL, McCrae KR, Fakhari FD, Dittmer DP, Renne R. An FQ, et al. J Virol. 2006 May;80(10):4833-46. doi: 10.1128/JVI.80.10.4833-4846.2006. J Virol. 2006. PMID: 16641275 Free PMC article.

9

Production of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.

Gaston DC, Odom CI, Li L, Markert JM, Roth JC, Cassady KA, Whitley RJ, Parker JN. Gaston DC, et al. Among authors: roth jc. PLoS One. 2013 Nov 27;8(11):e81768. doi: 10.1371/journal.pone.0081768. eCollection 2013. PLoS One. 2013. PMID: 24312353 Free PMC article.

10

Oncolytic viral therapy: targeting cancer stem cells.

Smith TT, Roth JC, Friedman GK, Gillespie GY. Smith TT, et al. Among authors: roth jc. Oncolytic Virother. 2014 Feb;2014(3):21-33. doi: 10.2147/OV.S52749. Oncolytic Virother. 2014. PMID: 24834430 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

46 results

Search Page

Filters